This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Barofold, Inc., University of Colorado. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2014
Title: Celebrating the Innovations of Amber Haynes Fradkin
Introduction: Amber Haynes Fradkin is a prominent inventor based in Golden, Colorado, recognized for her significant contributions to the field of therapeutic protein compositions. With her innovative mindset and dedication to enhancing healthcare solutions, she has made a lasting impact through her patented invention.
Latest Patents: Amber holds a patent for her invention titled "Method for reducing immunogenicity of therapeutic protein compositions." This groundbreaking invention provides methods for reducing and evaluating the immunogenic potential of therapeutic protein preparations. Her work focuses on developing pharmaceutical compositions that possess low immunogenic potential and improved efficacy. By assessing the presence of subvisible protein particulates in therapeutic preparations, Amber ensures that these preparations maintain safety and efficacy, ultimately benefiting patient treatment outcomes.
Career Highlights: Throughout her career, Amber has worked with renowned institutions, including the University of Colorado and Barofold, Inc. Her experience in these organizations has allowed her to combine research and innovation effectively, pushing the boundaries of what is possible in therapeutic treatments.
Collaborations: Amber's journey has been enriched by her collaboration with notable professionals in her field, including Matthew B. Seefeldt and Theodore W. Randolph. These partnerships have fostered a creative exchange of ideas and have significantly contributed to the advancement of her work.
Conclusion: Amber Haynes Fradkin stands out as an inventor whose work addresses critical challenges in therapeutic protein applications. Her patented method not only enhances the safety of pharmaceutical compositions but also emphasizes the importance of innovation in improving healthcare solutions. As she continues her innovative journey, the medical and scientific communities eagerly anticipate her future contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile